Cited by 418Lipoproteins and Cardiovascular HealthLipid metabolism and disordersCholesterol and Lipid Metabolism

The DOI matches its Crossref record; 153 of the 153 references it cites were found in a registry or an index.

Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing

McCrindle, Brian W., Urbina, Elaine M., Dennison, Barbara A., Jacobson, Marc S., Steinberger, Julia, Rocchini, Albert P., Hayman, Laura L., Daniels, Stephen R.·2007·Circulation

DOI 10.1161/circulationaha.107.181946

Open this paper in CoChat — free account

Abstract

Despite compliance with lifestyle recommendations, some children and adolescents with high-risk hyperlipidemia will require lipid-lowering drug therapy, particularly those with familial hypercholesterolemia. The purpose of this statement is to examine new evidence on the association of lipid abnormalities with early atherosclerosis, discuss challenges with previous guidelines, and highlight results of clinical trials with statin therapy in children and adolescents with familial hypercholesterolemia or severe hypercholesterolemia. Recommendations are provided to guide decision-making with regard to patient selection, initiation, monitoring, and maintenance of drug therapy.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.107.181946

Cites

153 of 153 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Prevalence and Trends in Overweight Among US Children and Adolescents, 1999-2000
Ogden, C. L. (2002) · JAMA · doi:10.1001/jama.288.14.1728 · Cited by 4,060
Association between Multiple Cardiovascular Risk Factors and Atherosclerosis in Children and Young Adults
Berenson, G. S., Srinivasan, S. R., Bao, W., Newman, W. P., Tracy, R. E., & Wattigney, W. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382302 · Cited by 4,032
A Definition of Advanced Types of Atherosclerotic Lesions and a Histological Classification of Atherosclerosis
Stary, H. C., Chandler, A. B., Dinsmore, R. E., Fuster, V., Glagov, S. K., Insull, W., Rosenfeld, M. E., Schwartz, C. J., Wagner, W. D., & Wissler, R. W. (1995) · Circulation · doi:10.1161/01.cir.92.5.1355 · Cited by 3,506
The Relation of Overweight to Cardiovascular Risk Factors Among Children and Adolescents: The Bogalusa Heart Study
Freedman, D. S., Dietz, W. H., Srinivasan, S. R., & Berenson, G. S. (1999) · Pediatrics · doi:10.1542/peds.103.6.1175 · Cited by 2,456
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420302 · Cited by 1,957
Relation of Body Fat Distribution to Metabolic Complications of Obesity*
KISSEBAH, A. H., VYDELINGUM, N., MURRAY, R., EVANS, D. J., KALKHOFF, R. K., & ADAMS, P. W. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-2-254 · Cited by 1,909
Overweight in Children and Adolescents
Daniels, S. R., Arnett, D. K., Eckel, R. H., Gidding, S. S., Hayman, L. L., Kumanyika, S., Robinson, T. N., Scott, B. J., Jeor, S. S., & Williams, C. L. (2005) · Circulation · doi:10.1161/01.cir.0000161369.71722.10 · Cited by 1,543
Self-citation
Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution.
Krotkiewski, M., Björntorp, P. A., Sjöström, L., & Smith, U. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111040 · Cited by 1,475
Homocysteine Lowering and Cardiovascular Events after Acute Myocardial Infarction
Bønaa, K. H., Njølstad, I., Ueland, P. M., Schirmer, H., Tverdal, A., Steigen, T., Wang, H., Nordrehaug, J. E., Arnesen, E., & Rasmussen, K. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055227 · Cited by 1,442

Show all 153 references

Research works printed but not linked: 13

10.1161/atvb.15.9.1512 · DOI
10.1161/circ.89.5.8181179 · DOI
10.1161/circ.103.11.1546 · DOI
10.1161/circ.103.22.2705 · DOI
10.1161/circ.104.23.2815 · DOI
10.1161/atvb.16.8.984 · DOI
10.1161/atvb.20.9.2070 · DOI
10.1161/circ.101.13.1533 · DOI
10.1161/hyp.26.6.984 · DOI
10.1016/S0891-5245(02)06571-9 · DOI
Firth JC, Marais AD, Byrnes P, Fusco RA, Bonnici F. Fluvastatin in heterozygous familial hypercholesterolemia. Cardiol Young. 2000; 10 (suppl 2): 35. Abstract.
10.1161/circ.102.13.1477 · DOI
10.1161/circ.94.6.1386 · DOI

Sorted by citations

Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
Standards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
Standards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Standards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications
Tabas, I., Williams, K. J., & Borén, J. (2007) · Circulation · doi:10.1161/circulationaha.106.676890 · Cited by 1,399
Lipid screening and cardiovascular health in childhood
Daniels, S. R., Greer, F. R., & and the Committee on Nutrition (2008) · Pediatrics · doi:10.1542/peds.2008-1349 · Cited by 1,178
Self-citation
Epidemiology of type 1 diabetes
Maahs, D. M., West, N. A., Lawrence, J. M., & Mayer-Davis, E. J. (2010) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2010.05.011 · Cited by 1,092
American Association of Clinical Endocrinologists and American College of Endocrinology guidelines for management of dyslipidemia and prevention of cardiovascular disease
Jellinger, P. S., Handelsman, Y., Rosenblit, P. D., Bloomgarden, Z. T., Fonseca, V. A., Garber, A. J., Grunberger, G., Guerin, C. K., Bell, D. S. H., Mechanick, J. I., et al. (2017) · Endocrine Practice · doi:10.4158/ep171764.appgl · Cited by 1,094
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
Newman, C. B., Preiss, D., Tobert, J. A., Jacobson, T. A., Page, R. L., II, Goldstein, L. B., Chin, C. C., Tannock, L. R., Miller, M. J., Raghuveer, G., et al. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atv.0000000000000073 · Cited by 790
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients
Goldberg, A. C., Hopkins, P. N., Toth, P. P., Ballantyne, C. M., Rader, D. J., Robinson, J. G., Daniels, S. R., Gidding, S. S., de Ferranti, S. D., Ito, M. K., et al. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.03.001 · Cited by 622
Self-citation
Long-term Cardiovascular Toxicity in Children, Adolescents, and Young Adults Who Receive Cancer Therapy: Pathophysiology, Course, Monitoring, Management, Prevention, and Research Directions
Lipshultz, S. E., Adams, M. J., Colan, S. D., Constine, L. S., Herman, E. H., Hsu, D. T., Hudson, M. M., Kremer, L. C. M., Landy, D. C., Miller, T. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182a88099 · Cited by 633
Self-citation
American Association of Clinical Endocrinologists' Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis
Jellinger, P. S., Smith, D. A., Mehta, A., Ganda, O. P., Handelsman, Y., Rodbard, H. W., Shepherd, M. D., & Seibel, J. A. (2012) · Endocrine Practice · doi:10.4158/ep.18.s1.1 · Cited by 533
Type 1 Diabetes Mellitus and Cardiovascular Disease
de Ferranti, S. D., de Boer, I. H., Fonseca, V. A., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000034 · Cited by 516
Cardiovascular Risk Reduction in High-Risk Pediatric Patients: A Scientific Statement From the American Heart Association
de Ferranti, S. D., Steinberger, J., Ameduri, R. K., Baker, A., Gooding, H. C., Kelly, A. S., Mietus‐Snyder, M., Mitsnefes, M. M., Peterson, A. L. H., St‐Pierre, J., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000618 · Cited by 464
Self-citation
Type 1 Diabetes Mellitus and Cardiovascular Disease: A Scientific Statement From the American Heart Association and American Diabetes Association
de Ferranti, S. D., de Boer, I. H., Fonseca, V. A., Fox, C. S., Golden, S. H., Lavie, C. J., Magge, S. N., Marx, N., McGuire, D. K., Orchard, T. J., et al. (2014) · Diabetes Care · doi:10.2337/dc14-1720 · Cited by 444
14. Children and Adolescents: Standards of Medical Care in Diabetes—2022
(2021) · Diabetes Care · doi:10.2337/dc22-s014 · Cited by 385
Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
Watts, G. F., Gidding, S. S., Wierzbicki, A. S., Toth, P. P., Rodrigo Alonso, K., Brown, W. V., Bruckert, É., Defesche, J. C., Lin, K. K., Livingston, M., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.11.025 · Cited by 384
13. Children and Adolescents: Standards of Medical Care in Diabetes−2020
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc20-s013 · Cited by 287
Statins for children with familial hypercholesterolemia
Vuorio, A. F., Kuoppala, J., Kovanen, P. T., Humphries, S. E., Tonstad, S., Wiegman, A., Drogari, E., & Ramaswami, U. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006401.pub4 · Cited by 264
Diagnosis and Management of Prediabetes in the Continuum of Hyperglycemia—When Do the Risks of Diabetes Begin? A Consensus Statement From the American College of Endocrinology and the American Association of Clinical Endocrinologists*
Garber, A. J., Handelsman, Y., EINHORN, D. F., Bergman, D. A., Bloomgarden, Z. T., Fonseca, V. A., Garvey, W. T., Gavin, J. R., Grunberger, G., Horton, E. S., et al. (2008) · Endocrine Practice · doi:10.4158/ep.14.7.933 · Cited by 239
13. Children and Adolescents: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s013 · Cited by 223
2018 Guidelines for the management of dyslipidemia
Rhee, E., Kim, H. C., Kim, J. H., Lee, E. Y., Kim, B. J., Kim, E. M., Song, Y., Lim, J. H., Kim, B. J., Choi, S., et al. (2019) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2019.188 · Cited by 221
Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: A study of a cohort of 14,000 mutation carriers
Besseling, J., Kindt, I., Hof, M. H. P., Kastelein, J. J. P., Hutten, B. A., & Hovingh, G. K. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.12.020 · Cited by 212
Reduction of Risk for Cardiovascular Disease in Children and Adolescents
Daniels, S. R., PRATT, C. A., & Hayman, L. L. (2011) · Circulation · doi:10.1161/circulationaha.110.016170 · Cited by 206
Self-citation
Familial hypercholesterolaemia: A model of care for Australasia
Watts, G. F., SULLIVAN, D. R., Poplawski, N. K., van Bockxmeer, F., Hamilton‐Craig, I. R., Clifton, P. M., O’Brien, R. C., Bishop, W., George, P. M., Barter, P. J., et al. (2011) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2011.06.001 · Cited by 206
14. Children and Adolescents: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D. M., Johnson, E. L., et al. (2022) · Diabetes Care · doi:10.2337/dc23-s014 · Cited by 224
13. Children and Adolescents: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc19-s013 · Cited by 208
A Pooled Analysis of Lacosamide Clinical Trial Data Grouped by Mechanism of Action of Concomitant Antiepileptic Drugs
Sake, J., Hebert, D., Isojärvi, J. I. T., Doty, P., Backer, M. D., Davies, K., Eggert‐Formella, A., & Zackheim, J. (2010) · CNS Drugs · doi:10.2165/11587550-000000000-00000 · Cited by 197
The Association of Pediatric Low- and High-Density Lipoprotein Cholesterol Dyslipidemia Classifications and Change in Dyslipidemia Status With Carotid Intima-Media Thickness in Adulthood
Magnussen, C. G., Venn, A., Thomson, R. J., Juonala, M., Srinivasan, S. R., Viikari, J. S. A., Berenson, G. S., Dwyer, T., & Raitakari, O. T. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.061 · Cited by 192
Cardiovascular Disease Risk Factors in Youth With Diabetes Mellitus
Maahs, D. M., Daniels, S. R., de Ferranti, S. D., Dichek, H. L., Flynn, J. T., Goldstein, B. I., Kelly, A. S., Nadeau, K. J., Martyn-Nemeth, P. A., Osganian, S. K., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000094 · Cited by 199
Self-citation
12. Children and Adolescents: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2017) · Diabetes Care · doi:10.2337/dc18-s012 · Cited by 204
2018 Guidelines for the Management of Dyslipidemia in Korea
Rhee, E., Kim, H. C., Kim, J. H., Lee, E. Y., Kim, B. J., Kim, E. M., Song, Y., Lim, J. H., Kim, B. J., Choi, S., et al. (2019) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2019.8.2.78 · Cited by 194
14. Children and Adolescents: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s014 · Cited by 173
Pediatric aspects of Familial Hypercholesterolemias: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia
Daniels, S. R., Gidding, S. S., & de Ferranti, S. D. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.03.453 · Cited by 173
Self-citation
Carotid Intima-Media Thickness in Children With Familial Hypercholesterolemia
Kusters, D. M., Wiegman, A., Kastelein, J. J. P., & Hutten, B. A. (2013) · Circulation Research · doi:10.1161/circresaha.114.301430 · Cited by 170
Efficacy and Safety of Rosuvastatin Therapy for Children With Familial Hypercholesterolemia
Avis, H. J., Hutten, B. A., Gagné, C., Langslet, G., McCrindle, B. W., Wiegman, A., Hsia, J. A., Kastelein, J. J. P., & Stein, E. A. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.042 · Cited by 168
Self-citation
14. Children and Adolescents: Standards of Care in Diabetes—2024
ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., Lingvay, I., et al. (2023) · Diabetes Care · doi:10.2337/dc24-s014 · Cited by 192
Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation
Watts, G. F., Gidding, S. S., Wierzbicki, A. S., Toth, P. P., Rodrigo Alonso, K., Brown, W. V., Bruckert, É., Defesche, J. C., Lin, K. K., Livingston, M., et al. (2014) · Journal of clinical lipidology · doi:10.1016/j.jacl.2014.01.002 · Cited by 165
Adolescence Risk Factors Are Predictive of Coronary Artery Calcification at Middle Age
Hartiala, O., Magnussen, C. G., Kajander, S. A., Knuuti, J. M., Ukkonen, H., Saraste, A., Rinta-Kiikka, I. C., Kainulainen, S., Kähönen, M. A. P., Hutri‐Kähönen, N., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.05.045 · Cited by 159
Utility of Currently Recommended Pediatric Dyslipidemia Classifications in Predicting Dyslipidemia in Adulthood
Magnussen, C. G., Raitakari, O. T., Thomson, R. J., Juonala, M., Patel, D. A., Viikari, J. S. A., Marniemi, J., Srinivasan, S. R., Berenson, G. S., Dwyer, T., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.718981 · Cited by 150
Management of familial hypercholesterolemia in children and young adults: Consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization
Descamps, O. S., Tenoutasse, S., Stéphenne, X., Gies, I., Beauloye, V., Lebrethon, M.-C., de Beaufort, C. E., Waele, K. D., Scheen, A. J., Rietzschel, E. R., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.06.016 · Cited by 149
Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia.
van der Graaf, A., Cuffie-Jackson, C., Vissers, M., Trip, M., Gagné, C., Shi, G., Veltri, E., Avis, H., & Kastelein, J. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.09.002 · Cited by 134
Primary Prevention of Cardiovascular Disease in Nursing Practice: Focus on Children and Youth
Hayman, L. L., Meininger, J. C., Daniels, S. R., McCrindle, B. W., Helden, L., Ross, J. D., Dennison, B. A., Steinberger, J., & Williams, C. L. (2007) · Circulation · doi:10.1161/circulationaha.107.184595 · Cited by 147
Self-citation
Familial Hypercholesterolemia
Bouhairie, V. E., & Goldberg, A. C. (2015) · Cardiology Clinics · doi:10.1016/j.ccl.2015.01.001 · Cited by 146
2015 Korean Guidelines for the Management of Dyslipidemia: Executive Summary (English Translation)
Committee for the Korean Guidelines for the Management of Dyslipidemia (2016) · Korean Circulation Journal · doi:10.4070/kcj.2016.46.3.275 · Cited by 123
Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities
Vuorio, A. F., Watts, G. F., Schneider, W. J., Tsimikas, S., & Kovanen, P. T. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12981 · Cited by 122
American Association of Clinical Endocrinologists’ Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis: Executive Summary
Jellinger, P. S., Smith, D. A., Mehta, A., Ganda, O. P., Handelsman, Y., Rodbard, H. W., Shepherd, M. D., Seibel, J. A., Kreisberg, R. A., & Goldberg, R. B. (2012) · Endocrine Practice · doi:10.4158/ep.18.2.269 · Cited by 113
Childhood risk factors predict cardiovascular disease, impaired fasting glucose plus type 2 diabetes mellitus, and high blood pressure 26 years later at a mean age of 38 years: the Princeton–lipid research clinics follow-up study
Morrison, J. A., Glueck, C. J., & Wang, P. (2011) · Metabolism · doi:10.1016/j.metabol.2011.08.010 · Cited by 107
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report
Armenian, S. H., Chemaitilly, W., Chen, M. Y., Chow, E. J., Duncan, C., Jones, L. W., Pulsipher, M. A., Remaley, A. T., Rovó, A., Salooja, N., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.08.019 · Cited by 109
Statins for children with familial hypercholesterolemia
Vuorio, A. F., Kuoppala, J., Kovanen, P. T., Humphries, S. E., Tonstad, S., Wiegman, A., Drogari, E., & Ramaswami, U. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006401.pub5 · Cited by 105
Effect of Rosuvastatin on Carotid Intima-Media Thickness in Children With Heterozygous Familial Hypercholesterolemia
Braamskamp, M. J. A. M., Langslet, G., McCrindle, B. W., Cassiman, D. M., Francis, G. A., Gagné, C., Gaudet, D., Morrison, K. M., Wiegman, A., Turner, T. A., et al. (2017) · Circulation · doi:10.1161/circulationaha.116.025158 · Cited by 103
Self-citation
Morphologic and metabolic abnormalities in vertically HIV-infected children and youth
Aldrovandi, G. M., Lindsey, J. C., Jacobson, D. L., Zadzilka, A., Sheeran, E., Moye, J., Borum, P. R., Meyer, W. A., Hardin, D. S., & Mulligan, K. M. (2009) · AIDS · doi:10.1097/qad.0b013e3283269dfb · Cited by 102
Screening for Lipid Disorders in Children: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force (2007) · PEDIATRICS · doi:10.1542/peds.2006-1812 · Cited by 99
Trends in the Prevalence of Chronic Medication Use in Children: 2002–2005
Cox, E. R., Halloran, D. R., Homan, S. M., Welliver, S., & MAGER, D. E. (2008) · PEDIATRICS · doi:10.1542/peds.2008-0214 · Cited by 96
Familial hypercholesterolemia: A review
Varghese, M. J. (2014) · Annals of Pediatric Cardiology · doi:10.4103/0974-2069.132478 · Cited by 98
Statin treatment of children with familial hypercholesterolemia – Trying to balance incomplete evidence of long-term safety and clinical accountability: Are we approaching a consensus?
Vuorio, A. F., Docherty, K. F., Humphries, S. E., Kuoppala, J., & Kovanen, P. T. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.10.032 · Cited by 92
Management of metabolic syndrome in children and adolescents
Pacifico, L., Anania, C., Martino, F., Poggiogalle, E., Chiarelli, F., Arca, M., & Chiesa, C. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2011.01.011 · Cited by 89
Glucose Control Predicts 2-Year Change in Lipid Profile in Youth with Type 1 Diabetes
Maahs, D. M., Dabelea, D., D'Agostino, R. B., Andrews, J. S., SHAH, A. S., Crimmins, N. A., Mayer‐Davis, E. J., Marcovina, S. M., Imperatore, G., Wadwa, R. P., et al. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.06.006 · Cited by 89
Self-citation
Pituitary adenomas in childhood, adolescence and young adulthood: presentation, management, endocrine and metabolic outcomes
Steele, C. A., MacFarlane, I. A., Blair, J., Cuthbertson, D. J., Didi, M., Mallucci, C. L., Javadpour, M., & Daousi, C. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0519 · Cited by 85
Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT
DeFilipp, Z. M., Duarte, R. F., Snowden, J. A., Majhail, N. S., Greenfield, D., López‐Miranda, J., Arat, M., Baker, K. S., Burns, L. J., Duncan, C., et al. (2016) · Bone Marrow Transplantation · doi:10.1038/bmt.2016.203 · Cited by 84
Paediatric screening for hypercholesterolaemia in Europe: Table 1
Kusters, D. M., de Beaufort, C. E., Widhalm, K., Guardamagna, O., Bratina, N., Ose, L., & Wiegman, A. (2011) · Archives of Disease in Childhood · doi:10.1136/archdischild-2011-300081 · Cited by 83
11. Children and Adolescents
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc16-s014 · Cited by 84
Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence
Preiss, D., & Sattar, N. A. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03490.x · Cited by 80
Cascade Screening for Familial Hypercholesterolemia (FH)
Ned, R. M., & Sijbrands, E. J. G. (2011) · PLoS Currents · doi:10.1371/currents.rrn1238 · Cited by 81
Colesevelam Hydrochloride: Efficacy and Safety in Pediatric Subjects with Heterozygous Familial Hypercholesterolemia
Stein, E. A., Marais, A. D., Szamosi, T., Raal, F. J., Schurr, D., Urbina, E. M., Hopkins, P. N., Karki, S., Xu, J., Misir, S., et al. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2009.08.037 · Cited by 78
Self-citation
11. Children and Adolescents
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc15-s014 · Cited by 83
Risk factors for cardiovascular disease and type 2 diabetes retained from childhood to adulthood predict adult outcomes: the Princeton LRC Follow-up Study
Morrison, J. A., Glueck, C. J., Woo, J. G., & Wang, P. (2012) · International Journal of Pediatric Endocrinology · doi:10.1186/1687-9856-2012-6 · Cited by 77
Vascular health in children and adolescents: effects of obesity and diabetes
Copeland, K. C., Short, K. R., Blackett, & Gardner (2009) · Vascular Health and Risk Management · doi:10.2147/vhrm.s7116 · Cited by 75
The treatment of hypercholesterolemic children: Efficacy and safety of a combination of red yeast rice extract and policosanols
Guardamagna, O., Abello, F., Baracco, V., Stasiowska, B., & Martino, F. (2010) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.10.015 · Cited by 74
Monogenic pediatric dyslipidemias: Classification, genetics and clinical spectrum
Rahalkar, A. R., & Hegele, R. A. (2007) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2007.10.007 · Cited by 77
Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia
Malhotra, A., Shafiq, N., Arora, A., Singh, M., Kumar, R., & Malhotra, S. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001918.pub3 · Cited by 72
12. Children and Adolescents
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc17-s015 · Cited by 71
Ezetimibe Treatment of Pediatric Patients with Hypercholesterolemia
Clauss, S. B., Wai, K., Kavey, R.-E. W., & KUEHL, K. S. (2009) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.12.044 · Cited by 66
Use of Statins for Dyslipidemia in the Pediatric Population
Eiland, L. S., & Luttrell, P. K. (2010) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-15.3.160 · Cited by 66
Association of Hypercholesterolemia Incidence With Antiretroviral Treatment, Including Protease Inhibitors, Among Perinatally HIV-Infected Children
Tassiopoulos, K., Williams, P. L., Seage, G. R., Crain, M. J., Oleske, J. M., & Farley, J. J. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181648e16 · Cited by 65
Metabolic Syndrome and Cardiovascular Disease after Hematopoietic Cell Transplantation: Screening and Preventive Practice Recommendations from the CIBMTR and EBMT
DeFilipp, Z. M., Duarte, R. F., Snowden, J. A., Majhail, N. S., Greenfield, D., López‐Miranda, J., Arat, M., Baker, K. S., Burns, L. J., Duncan, C., et al. (2016) · Transplantation and Cellular Therapy · doi:10.1016/j.bbmt.2016.05.007 · Cited by 64
Ezetimibe-associated adverse effects: what the clinician needs to know
Florentin, M., Liberopoulos, E. N., & Elisaf, M. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01592.x · Cited by 64
Spectrum and Management of Hypertriglyceridemia Among Children in Clinical Practice
Manlhiot, C., Larsson, P., Gurofsky, R. C., Smith, R. W., Fillingham, C., Clarizia, N. A., Chahal, N., Clarke, J., & McCrindle, B. W. (2009) · PEDIATRICS · doi:10.1542/peds.2008-0367 · Cited by 64
Self-citation
Identification and treatment of metabolic complications in pediatric obesity
Ode, K. L., Frohnert, B. I., & Nathan, B. M. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-009-9115-7 · Cited by 64
2015 Korean Guidelines for Management of Dyslipidemia
Committee for Guidelines for Management of Dyslipidemia (2015) · Journal of Lipid and Atherosclerosis · doi:10.12997/jla.2015.4.1.61 · Cited by 65
Long-Term Statin Treatment in Children with Familial Hypercholesterolemia: More Insight into Tolerability and Adherence
Braamskamp, M. J. A. M., Kusters, D. M., Avis, H. J., Smets, E. M. A., Wijburg, F. A., Kastelein, J. J. P., Wiegman, A., & Hutten, B. A. (2015) · Pediatric Drugs · doi:10.1007/s40272-014-0116-y · Cited by 61
An update on the assessment and management of metabolic syndrome, a growing medical emergency in paediatric populations
Mameli, C., Zuccotti, G., Carnovale, C., Galli, E., Nannini, P., Cervia, D., & Perrotta, C. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.01.017 · Cited by 63
Altered Clock and Lipid Metabolism-Related Genes in Atherosclerotic Mice Kept with Abnormal Lighting Condition
Zhu, Z., Hua, B., Shang, Z., Yuan, G., Xu, L., Li, E., Li, X., Sun, N., Yan, Z., Qian, R., et al. (2016) · BioMed Research International · doi:10.1155/2016/5438589 · Cited by 60
Statins for children with familial hypercholesterolemia
Vuorio, A. F., Kuoppala, J., Kovanen, P. T., Humphries, S. E., Strandberg, T. E., Tonstad, S., & Gylling, H. K. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006401.pub2 · Cited by 59
Maternal-foetal epigenetic interactions in the beginning of cardiovascular damage
Claudio Napoli, A., Infante, T., & Casamassimi, A. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr201 · Cited by 57
Dyslipidemia in Youth with Diabetes: To Treat or Not to Treat?
Maahs, D. M., Wadwa, R. P., Bishop, F. K., Daniels, S. R., Rewers, M., & KLINGENSMITH, G. J. (2008) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2008.05.062 · Cited by 56
Self-citation
Childhood origins of arterial disease
Charakida, M., Deanfield, J. E., & Halcox, J. (2007) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3282eff585 · Cited by 55
Statins for children with familial hypercholesterolemia
Vuorio, A. F., Kuoppala, J., Kovanen, P. T., Humphries, S. E., Tonstad, S., Wiegman, A., & Drogari, E. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006401.pub3 · Cited by 55
Population Trends Toward Increasing Cardiovascular Risk Factors in Canadian Adolescents
McCrindle, B. W., Manlhiot, C., Millar, K., Gibson, D., Stearne, K., Kilty, H. L., Prentice, D., Wong, H., Chahal, N., & Dobbin, S. W. (2010) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.05.014 · Cited by 53
Self-citation
14. Children and Adolescents: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s014 · Cited by 70
Therapeutic Benefits of Al-hijamah: in Light of Modern Medicine and Prophetic Medicine
Sayed, S. M. E., Al-quliti, A.-S., Mahmoud, H. S., Baghdadi, H., Maria, R. A., Nabo, M. M. H., & Hefny, A. (2014) · American journal of medical and biological research · doi:10.12691/ajmbr-2-2-3 · Cited by 52
Diabetes complications in childhood and adolescent onset type 2 diabetes—a review
Amutha, A., & Mohan, V. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.02.009 · Cited by 52
Prevalence of Antihypertensive, Antidiabetic, and Dyslipidemic Prescription Medication Use Among Children and Adolescents
Liberman, J. N., Berger, J. E., & Lewis, M. W. (2009) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpediatrics.2009.5 · Cited by 52
Influence of food intake, age, gender, HbA1c, and BMI levels on plasma cholesterol in 29 979 children and adolescents with type 1 diabetes - reference data from the German diabetes documentation and quality management system (DPV)
Schwab, K. O., Doerfer, J., Naeke, A., Rohrer, T. R., Wiemann, D., Marg, W., Hofer, S. E., Holl, R. W., & Initiative, G. P. D. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00469.x · Cited by 51
A systematic review of bile acid sequestrant therapy in children with familial hypercholesterolemia
Davidson, M. H. (2011) · Journal of clinical lipidology · doi:10.1016/j.jacl.2011.01.005 · Cited by 51
Phytosterols for dyslipidemia
Malinowski, J. M., & Gehret, M. M. (2010) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp090427 · Cited by 50
Ethical issues of clinical trials in children: a European perspective
Sammons, H. M. (2009) · Archives of Disease in Childhood · doi:10.1136/adc.2008.149898 · Cited by 50
Longitudinal screening of serum lipids in children and adolescents with Type 1 diabetes in a UK clinic population
Edge, J., James, T. J., & Shine, B. S. F. (2008) · Diabetic Medicine · doi:10.1111/j.1464-5491.2008.02518.x · Cited by 50

Authors: McCrindle, B. W., Urbina, E. M., Dennison, B. A., Jacobson, M. S., Steinberger, J., Rocchini, A. P., Hayman, L. L., & Daniels, S. R.
Affiliations: Hospital for Sick Children (CA)
ORCID: McCrindle, Brian W.
Urbina, Elaine M.
Dennison, Barbara A.
Steinberger, Julia
Hayman, Laura L.
Daniels, Stephen R.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2007-04-10
Volume: 115
Issue: 14
Pages: 1948-1967
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.107.181946
OpenAlex: W2070344375
Cited by: 418
References: 153
Citations by year: 2026: 5 · 2025: 5 · 2024: 5 · 2023: 5 · 2022: 5 · 2021: 8 · 2020: 19 · 2019: 11 · 2018: 7 · 2017: 12 · 2016: 18 · 2015: 23 · 2014: 26 · 2013: 32 · 2012: 36
FWCI: 53.43
Type: journal article
Language: en
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
Keywords: familial hypercholesterolemia, severe hypercholesterolemia, lipid-lowering therapy, statins, early atherosclerosis, children and adolescents, patient selection, treatment monitoring
MeSH terms: Contraindications, Adolescent, Adult, Age Factors, Anticholesteremic Agents, Hypolipidemic Agents, Arteriosclerosis, Child, Child, Preschool, Cholesterol, Dietary, Clinical Trials as Topic, Combined Modality Therapy, Dietary Fats, Exercise Therapy, Female, Humans, Hyperlipoproteinemia Type II, Hyperlipoproteinemias, Infant, Cholesterol, LDL, Male, Phytotherapy, Middle Aged, Obesity, Risk Factors, Ultrasonography, HIV Infections, HIV Protease Inhibitors, Age of Onset, Disease Progression, Diet, Fat-Restricted, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Metabolic Syndrome, Diabetes Complications, Dyslipidemias

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents: A Scientific Statement From the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, With the Council on Cardiovascular Nursing

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks